GSK coughs up $2B for Bellus Health
J&J records $130M restructuring expense in Q1 overhaul of infectious disease unit
Supreme Court slaps down separate bids from Novartis, Sanofi
After lupus setback, Nektar sticks with immunology but lays off 70% of hometown workforce
*please scroll down for all the latest news*
